This work is licensed under the Creative Commons Attribution 4.0 International License.
Morales-Alvarez MC. Nephrotoxicity of antimicrobials and antibiotics. Adv Chronic Kidney Dis. 2020; 27:31–7.Morales-AlvarezMC.Nephrotoxicity of antimicrobials and antibiotics202027317Search in Google Scholar
Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available from: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/Adult_OI.pdf. [Last accessed on 2021 Jan 22].Panel on Opportunistic Infections in Adults and Adolescents with HIVAvailable from: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/Adult_OI.pdf. [Last accessed on 2021 Jan 22].Search in Google Scholar
Llanos A, Cieza J, Bernardo J, Echevarria J, Biaggioni I, Sabra R, Branch RA. Effect of salt supplementation on amphotericin B nephrotoxicity. Kidney Int. 1991; 40:302–8.LlanosACiezaJBernardoJEchevarriaJBiaggioniISabraRBranchRA.Effect of salt supplementation on amphotericin B nephrotoxicity1991403028Search in Google Scholar
Berdichevski RH, Luis LB, Crestana L, Manfro RC. Amphotericin B-related nephrotoxicity in low-risk patients. Braz J Infect Dis. 2006; 10:94–9.BerdichevskiRHLuisLBCrestanaLManfroRC.Amphotericin B-related nephrotoxicity in low-risk patients200610949Search in Google Scholar
Echevarria J, Seas C, Cruz M, Chávez E, Campos M, Cieza J, et al. Oral rehydration solution to prevent nephrotoxicity of amphotericin B. Am J Trop Med Hyg. 2006; 75:1108–12.EchevarriaJSeasCCruzMChávezECamposMCiezaJOral rehydration solution to prevent nephrotoxicity of amphotericin B200675110812Search in Google Scholar
Techapornroong M, Suankratay C. Alternate-day versus once-daily administration of amphotericin B in the treatment of cryptococcal meningitis: a randomized controlled trial. Scand J Infect Dis. 2007; 39:896–901.TechapornroongMSuankratayC.Alternate-day versus once-daily administration of amphotericin B in the treatment of cryptococcal meningitis: a randomized controlled trial200739896901Search in Google Scholar
Bicanic T, Bottomley C, Loyse A, Brouwer AE, Muzoora C, Taseera K, et al. Toxicity of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated cryptococcal meningitis. Antimicrob Agents Chemother. 2015; 59:7224–31.BicanicTBottomleyCLoyseABrouwerAEMuzooraCTaseeraKToxicity of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated cryptococcal meningitis201559722431Search in Google Scholar
Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Inter Suppl. 2012; 2:1–138.KellumJALameireNAspelinPBarsoumRSBurdmannEAGoldsteinSLKidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury201221138Search in Google Scholar
Sawaya BP, Briggs JP, Schnermann J. Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties. J Am Soc Nephrol. 1995; 6:154–64.SawayaBPBriggsJPSchnermannJ.Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties1995615464Search in Google Scholar
Karimzadeh I, Farsaei S, Khalili H, Dashti-Khavidaki S. Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity? Expert Opin Drug Saf. 2012; 11:969–83.KarimzadehIFarsaeiSKhaliliHDashti-KhavidakiS.Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity?20121196983Search in Google Scholar
Arning M, Scharf RE. Prevention of amphotericin-B-induced nephrotoxicity by loading with sodium chloride: a report of 1291 days of treatment with amphotericin B without renal failure. Klin Wochenschr. 1989; 67:1020–8.ArningMScharfRE.Prevention of amphotericin-B-induced nephrotoxicity by loading with sodium chloride: a report of 1291 days of treatment with amphotericin B without renal failure19896710208Search in Google Scholar
Bates DW, Su L, Yu DT, Chertow GM, Seger DL, Gomes DR, Platt R. Correlates of acute renal failure in patients receiving parenteral amphotericin B. Kidney Int. 2001; 60:1452–9.BatesDWSuLYuDTChertowGMSegerDLGomesDRPlattR.Correlates of acute renal failure in patients receiving parenteral amphotericin B20016014529Search in Google Scholar
Harbarth S, Pestotnik SL, Lloyd JF, Burke JP, Samore MH. The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy. Am J Med. 2001; 111:528–34.HarbarthSPestotnikSLLloydJFBurkeJPSamoreMH.The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy200111152834Search in Google Scholar
Gubbins PO, Penzak SR, Polston S, McConnell SA, Anaissie E. Characterizing and predicting amphotericin B-associated nephrotoxicity in bone marrow or peripheral blood stem cell transplant recipients. Pharmacotherapy. 2002; 22:961–71.GubbinsPOPenzakSRPolstonSMcConnellSAAnaissieE.Characterizing and predicting amphotericin B-associated nephrotoxicity in bone marrow or peripheral blood stem cell transplant recipients20022296171Search in Google Scholar
Gabbai FB. The role of renal response to amino acid infusion and oral protein load in normal kidneys and kidney with acute and chronic disease. Curr Opin Nephrol Hypertens. 2018; 27:23–9.GabbaiFB.The role of renal response to amino acid infusion and oral protein load in normal kidneys and kidney with acute and chronic disease201827239Search in Google Scholar
Luke RG, Galla JH. It is chloride depletion alkalosis, not contraction alkalosis. J Am Soc Nephrol. 2012; 23:204–7.LukeRGGallaJH.It is chloride depletion alkalosis, not contraction alkalosis2012232047Search in Google Scholar